US Pharma MarketingA psychedelic-like drug for a Parkinson's symptom, mice with half-human brains, and more biotech news in the Readout newsletter. Cancer research patients Newsletters Log In My Account Subscribe Now My Account Settings Complete your personal information for a more tailored experience Saved Stories Billing Log Out Reporting from the frontiers of health and medicine Newsletters Log In My Account Subscribe Now Biotech Pharma Public Health Health Tech Policy Science First Opinion STAT+ STAT Events Search Log In Try STAT+ My Account My Account Settings Saved Stories Billing History Home Newsletter The Readout New startup to test psychedelic-like drug against Parkinson’s…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The FDA’s new hiring push is hitting some complications. Also, a startup is bringing a psychedelic-esque drug to Parkinson’s, and we’ve got mice with human-esque brains.
This WIRED video on Stone Age AI slop is on in the background for me right now, and I enjoy this quote from anthropologist Agustín Fuentes: “Why invent garbage when you actually have science?”
Source: STAT News Pharma